Search:
2024: Multiorgan manifestations of COL4A1 and COL4A2 variants and proposal for a clinical management protocol
COL4A1/2 variants are associated with highly variable multiorgan manifestations. Depicting the whole clinical spectrum of COL4A1/2-related manifestations is challenging, and there is no consensus on management and preventative strategies.
Patricia Musolino - Gene therapy for rare genetic vascular disorders
1st COL4A1-A2 European Conference - Patricia Musolino - Gene therapy for rare genetic vascular disorders: a patient-driven journey in drug development
2022: Systematic Review of Cerebral Phenotypes Associated With Monogenic Cerebral Small-Vessel Disease
Background Cerebral small-vessel disease (cSVD) is an important cause of stroke and vascular dementia. Most cases are multifactorial, but an emerging minority have a monogenic cause. While NOTCH3 is the best-known gene, several others have been reported. We aimed to summarize the cerebral phenotypes associated with these more recent cSVD genes.
2021: Hereditary Cerebral Small Vessel Diseases and Stroke: A Guide for Diagnosis and Management
Background Cerebral small-vessel disease (cSVD) is an important cause of stroke and vascular dementia. Most cases are multifactorial, but an emerging minority have a monogenic cause. While NOTCH3 is the best-known gene, several others have been reported. We aimed to summarize the cerebral phenotypes associated with these more recent cSVD genes.
Gould syndrome patient registry article
Recently, patient advocacy groups started using the name Gould syndrome to describe clinical features ofCOL4A1 and COL4A2 mutations. Gould syndrome is increasingly identified in genetic screening panels,and because it is a rare disease, there is a disproportionate burden on families to understand the diseaseand chart the course for clinical care. Among the chief concerns for […]
Research Paper: 2019 Nau
COL4A1 mutations in two infants with congenital cataracts and porencephaly: an ophthalmologic perspective
Research Paper: 2019 Labelle-Dumais
COL4A1 Mutations Cause Neuromuscular Disease with Tissue-Specific Mechanistic Heterogeneity
Research Paper: 2019 Watanabe
Malignant Hyperthermia and Cerebral Venous Sinus Thrombosis After Ventriculoperitoneal Shunt in Infant with Schizencephaly and COL4A1 Mutation
Research Paper: 2019 Jones
4-Sodium phenyl butyric acid has both efficacy and counter-indicative effects in the treatment of Col4a1 disease
Research Paper: 2018 Cavallin
Further refinement of COL4A1 and COL4A2 related cortical malformations
Research Paper: 2018 Hayashi
Use of sodium 4-phenylbutyrate to define therapeutic parameters for reducing intracerebral hemorrhage and myopathy in Col4a1 mutant mice
Research Paper: 2018 Ratelade
Severity of arterial defects in the retina correlates with the burden of intracerebral haemorrhage in COL4A1-related stroke
Research Paper: 2018 Cornec-Le Gall
The Value of Genetic Testing in Polycystic Kidney Diseases Illustrated by a Family With PKD2 and COL4A1 Mutations
Research Paper: 2017 Mao
Genetic dissection of anterior segment dysgenesis caused by a Col4a1 mutation in mouse
Research Paper: 2017 Trouillet
Col4a1 mutation generates vascular abnormalities correlated with neuronal damage in a mouse model of HANAC syndrome
Research Paper: 2017 Abe
A severe pulmonary complication in a patient with COL4A1-related disorder: A case report
Research Paper: 2017 Jeanne
Genotype-phenotype correlations in pathology caused by collagen type IV alpha 1 and 2 mutations